✦ LIBER ✦

Effects of Recombinant Human Hyaluronidase (rHuPH20) on Subcutaneous Administration of 10% and 20% IgG in Yucatan Mini Pigs

✍ Scribed by Bee, W.H.; Nekoroski, T.; Zhang, L.; Kang, D.; Teschner, W.; Schwarz, H.P.; Muchitsch, E.M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Contribution of Recombinant Human Hyalur

✍ Nekoroski, T. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Improving Subcutaneous Delivery of IgG v

✍ Zepeda, M.L.; Fu, G.Y.; Anderson, J.M.; Haller, M.F.; Kang, D.W. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Tolerability of Human Immunoglobulin 10%

✍ Gelmont, D.; Wasserman, R.L.; Melamed, I.; Stein, M.; Rubinstein, A.; McCoy, B.; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Pharmacokinetics (PK) of Human Immunoglo

✍ Rubinstein, A.; Wasserman, R.L.; Melamed, I.; Stein, M.; McCoy, B.; Engl, W.; Le 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Recombinant Human Hyaluronidase (rHuPH20

✍ Kang, D.W.; Jadin, L.M.; Nekoroski, T.A.; Zepeda, M.L. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Safety, Pharmacokinetics (PK), and Pharm

✍ Schranz, J.; Levy, R.; Lumry, W.; Manning, M.; Jacobs, J.; Dychter, S.S.; LaBarr 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 38 KB